HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis
2020-06-01
|
| Series: | Hepatic Oncology |
| Subjects: | |
| Online Access: | https://www.futuremedicine.com/doi/10.2217/hep-2020-0010 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850152825242255360 |
|---|---|
| author | Devis Pascut Muhammad Yogi Pratama Claudio Tiribelli |
| author_facet | Devis Pascut Muhammad Yogi Pratama Claudio Tiribelli |
| author_sort | Devis Pascut |
| collection | DOAJ |
| format | Article |
| id | doaj-art-c438652d6a98482da7c8afeaf5572abc |
| institution | OA Journals |
| issn | 2045-0923 2045-0931 |
| language | English |
| publishDate | 2020-06-01 |
| publisher | Taylor & Francis |
| record_format | Article |
| series | Hepatic Oncology |
| spelling | doaj-art-c438652d6a98482da7c8afeaf5572abc2025-08-20T02:25:51ZengTaylor & FrancisHepatic Oncology2045-09232045-09312020-06-017210.2217/hep-2020-0010HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillanceDevis Pascut0Muhammad Yogi Pratama1Claudio Tiribelli21Fondazione Italiana Fegato – ONLUS, Liver Research Center, AREA Science Park, ss14, Km163.5, Basovizza, 34149 Trieste, Italy1Fondazione Italiana Fegato – ONLUS, Liver Research Center, AREA Science Park, ss14, Km163.5, Basovizza, 34149 Trieste, Italy1Fondazione Italiana Fegato – ONLUS, Liver Research Center, AREA Science Park, ss14, Km163.5, Basovizza, 34149 Trieste, Italyhttps://www.futuremedicine.com/doi/10.2217/hep-2020-0010biomarkersDAAdirect-acting antiviralHCCHCV |
| spellingShingle | Devis Pascut Muhammad Yogi Pratama Claudio Tiribelli HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance Hepatic Oncology biomarkers DAA direct-acting antiviral HCC HCV |
| title | HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance |
| title_full | HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance |
| title_fullStr | HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance |
| title_full_unstemmed | HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance |
| title_short | HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance |
| title_sort | hcc occurrence after daa treatments molecular tools to assess the post treatment risk and surveillance |
| topic | biomarkers DAA direct-acting antiviral HCC HCV |
| url | https://www.futuremedicine.com/doi/10.2217/hep-2020-0010 |
| work_keys_str_mv | AT devispascut hccoccurrenceafterdaatreatmentsmoleculartoolstoassesstheposttreatmentriskandsurveillance AT muhammadyogipratama hccoccurrenceafterdaatreatmentsmoleculartoolstoassesstheposttreatmentriskandsurveillance AT claudiotiribelli hccoccurrenceafterdaatreatmentsmoleculartoolstoassesstheposttreatmentriskandsurveillance |